Diethylenetriaminepentaacetic acid (DTPA)

CAS No.: 67-43-6

Molecular formula: C₁₄H₂₃N₃O₁₀

Molecular weight: 393.35

Quality standard: CP

Characteristics: White powder

Content (HPLC): ≥99.0%

Packing: 2.5KG/ drum

Storage: Protected from light, sealed tightly

Three factors of renal injury induced by Contrast Media: Osmotic pressure, Viscosity and the total iodine. Reduced iodine intake is a feasible strategy to avoid kidney damage.

In order to minimize the potential risks associated with gadolinium deposition in the brain, it must be used in strict accordance with the indications and approved doses. It is recommended to use the lowest approved dose that meets the requirement of diagnosis and perform a careful benefit-risk assessment and patient informed communication before repeated administration.

Beijing beilu pharmaceutical co ltd is a professional contrast media manufacturing companies, we provide ct contrast agent, mri contrast medium, dtpa diethylenetriaminepentaacetic acid and etc. Want to know more? Please contact us.